Literature DB >> 9858117

Enhanced angiotensin II stimulates renal disorders in transgenic Tsukuba hypertensive mice.

T Kai1, K Sugimura, S Shimada, A Kurooka, T Takenaka, K Ishikawa.   

Abstract

Tsukuba hypertensive mice (THMs) are transgenic mice carrying human renin-angiotensin system (RAS) genes. The aim of this study is to evaluate whether renal disorders are present in THMs. Twenty-week-old THMs and C57BL/6 mice (C57s) were used for this study. Each group consisted of 8 mice. Systolic blood pressure, urinary volume, water intake and urinary albumin excretion were measured in each mouse. Each mouse was then euthanized, and the renal glomerulosclerosis index and glomerular size were measured. Systolic blood pressure of THMs was about 40 mmHg higher than that of C57s. Urinary volume, water intake and urinary albumin excretion were significantly higher in THMs than in C57s. The renal glomerulosclerosis index and glomerular size were also significantly higher in THMs than in C57s. These results suggested that an enhanced renin-angiotensin system, including its hypertensive effects, stimulates albuminuria, renal glomerulosclerosis and glomerular hypertrophy in THMs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858117     DOI: 10.1080/080370598437286

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  2 in total

1.  Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.

Authors:  Shigetaka Yoshida; Kenichi Ishizawa; Nobuhiro Ayuzawa; Kohei Ueda; Maki Takeuchi; Wakako Kawarazaki; Toshiro Fujita; Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2013-10-24       Impact factor: 2.801

2.  Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.

Authors:  Alex A Gutsol; Paula Blanco; Taben M Hale; Jean-Francois Thibodeau; Chet E Holterman; Rania Nasrallah; Jose W N Correa; Sergey A Afanasiev; Rhian M Touyz; Chris R J Kennedy; Dylan Burger; Richard L Hébert; Kevin D Burns
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.